永安药业
(002365)
| 流通市值：65.69亿 | | | 总市值：78.83亿 |
| 流通股本：2.46亿 | | | 总股本：2.95亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 211,651,545.97 | 320,405,292.96 | 193,149,436.01 | 242,036,774.3 |
| 应收票据及应收账款 | 141,114,835.18 | 160,680,293.89 | 144,658,543.53 | 173,737,472.81 |
| 其中：应收票据 | 10,979,043.41 | 6,712,910 | 729,283.49 | 1,490,060.91 |
| 应收账款 | 130,135,791.77 | 153,967,383.89 | 143,929,260.04 | 172,247,411.9 |
| 应收款项融资 | 200,000 | 1,106,263.2 | 1,347,000 | 432,335.45 |
| 预付款项 | 10,318,083.88 | 10,333,758.27 | 9,903,947.16 | 5,240,425.63 |
| 其他应收款合计 | 3,834,725.7 | 6,144,785.84 | 5,647,178.95 | 7,764,678.96 |
| 存货 | 90,319,474.84 | 93,502,681.55 | 92,119,067.35 | 85,224,057.41 |
| 其他流动资产 | 7,094,280.15 | 6,325,212.57 | 6,352,397.59 | 4,656,498.03 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,155,179,176.47 | 1,198,658,681.34 | 1,140,158,277.77 | 1,174,427,006.34 |
| 非流动资产: | | | | |
| 长期股权投资 | 75,213,058.4 | 74,547,492.91 | 74,301,627.11 | 73,030,694.26 |
| 固定资产 | 861,000,721.49 | 881,816,043.56 | 909,322,028.5 | 910,848,801.55 |
| 在建工程 | 76,945,854.9 | 66,409,104.74 | 55,653,283.06 | 55,530,119.18 |
| 无形资产 | 79,450,782.53 | 79,559,070.1 | 80,409,187.55 | 81,261,709.88 |
| 商誉 | - | - | 517,416.38 | 517,416.38 |
| 递延所得税资产 | 6,577,279.94 | 5,839,916.81 | 12,344,310.38 | 12,203,646.32 |
| 其他非流动资产 | 1,216,935.66 | 1,772,596.39 | 5,201,618.78 | 6,736,768.53 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,100,404,632.92 | 1,109,944,224.51 | 1,137,749,471.76 | 1,140,129,156.1 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,255,583,809.39 | 2,308,602,905.85 | 2,277,907,749.53 | 2,314,556,162.44 |
| 流动负债: | | | | |
| 短期借款 | 29,500,000 | 39,526,078.47 | 20,000,000 | 20,000,000 |
| 应付票据及应付账款 | 120,162,367.53 | 124,018,386.07 | 117,616,035.84 | 130,342,443.94 |
| 应付账款 | 120,162,367.53 | 124,018,386.07 | 117,616,035.84 | 130,342,443.94 |
| 合同负债 | 22,196,254.54 | 19,279,795.04 | 19,119,920.99 | 11,919,556.17 |
| 应付职工薪酬 | 24,290,218.37 | 38,857,601.21 | 33,661,799.07 | 29,209,248.72 |
| 应交税费 | 5,784,227.33 | 9,001,779.73 | 6,029,724.65 | 6,661,209.22 |
| 其他应付款合计 | 7,732,062.51 | 8,904,431.95 | 8,304,665.16 | 38,902,998.68 |
| 应付股利 | - | - | - | 29,282,145 |
| 其他流动负债 | 8,728,929.71 | 8,752,632.09 | 3,764,455.66 | 4,082,222.7 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 218,394,059.99 | 248,340,704.56 | 208,496,601.37 | 241,117,679.43 |
| 非流动负债: | | | | |
| 递延收益 | 6,996,465.37 | 7,457,212.42 | 7,134,630.23 | 7,575,008.54 |
| 递延所得税负债 | 10,234,256.83 | 10,747,760.55 | 21,298,748.87 | 22,599,743.58 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 17,230,722.2 | 18,204,972.97 | 28,433,379.1 | 30,174,752.12 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 235,624,782.19 | 266,545,677.53 | 236,929,980.47 | 271,292,431.55 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 294,682,500 | 294,682,500 | 294,682,500 | 294,682,500 |
| 资本公积 | 714,435,114.7 | 714,435,114.7 | 714,430,398.68 | 714,430,398.68 |
| 减:库存股 | 40,475,988.99 | 24,183,171.45 | 24,183,171.45 | 13,230,185.47 |
| 其他综合收益 | 2,391,184.39 | 2,401,801.91 | 2,216,858.16 | 2,336,494.38 |
| 专项储备 | 21,550,891.57 | 20,539,424.71 | 21,373,695.84 | 20,352,845.63 |
| 盈余公积 | 148,676,496.29 | 148,676,496.29 | 140,732,457.83 | 140,732,457.83 |
| 未分配利润 | 832,861,541.68 | 837,228,722.92 | 845,261,982.59 | 835,891,956.44 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,974,121,739.64 | 1,993,780,889.08 | 1,994,514,721.65 | 1,995,196,467.49 |
| 少数股东权益 | 45,837,287.56 | 48,276,339.24 | 46,463,047.41 | 48,067,263.4 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,019,959,027.2 | 2,042,057,228.32 | 2,040,977,769.06 | 2,043,263,730.89 |
| 负债和股东权益合计 | 2,255,583,809.39 | 2,308,602,905.85 | 2,277,907,749.53 | 2,314,556,162.44 |
| 公告日期 | 2025-04-29 | 2025-04-10 | 2024-10-30 | 2024-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |